We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measurement of Glycaemic Responses of Bakery and Confectionery Products (GIFA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01454219
First Posted: October 18, 2011
Last Update Posted: February 15, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Fazer Bakeries Ltd.
Information provided by (Responsible Party):
Clinical Life Sciences Ltd.
October 14, 2011
October 18, 2011
February 15, 2012
August 2011
January 2012   (Final data collection date for primary outcome measure)
Glycemic index (GI)
The 2 hours glycemic responses to bakery and confectionery products (the incremental area under the glucose response curve, IAUC).
Same as current
Complete list of historical versions of study NCT01454219 on ClinicalTrials.gov Archive Site
  • Insulin index (II)
    The 2 hours insulinemic responses to bakery and confectionery products (the incremental area under the insulin response curve, IAUC).
  • Glycemic load (GL)
Same as current
Not Provided
Not Provided
 
Measurement of Glycaemic Responses of Bakery and Confectionery Products
Measurement of Glycaemic Responses of Bakery and Confectionery Products
This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Healthy
Other: Bakery and confectionary products
Control product: Glucose solution, Test products: 11 bakery and confectionary products
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
14
January 2012
January 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • voluntarily given written consent for participation in research
  • healthy man or women, age between 18 ang 65 years
  • regular eating
  • Body Mass Index 18,5 - 24,9 kg/m2

Exclusion Criteria:

  • diabetes
  • gastrointestinal diseases
  • hepatic, kidney, pancreas or thyroid disease or disorder
  • arthritis
  • pregnancy or breast feeding
  • smoking
  • allergy
  • severe diseases
  • blood donation
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Finland
 
 
NCT01454219
GIFA
Not Provided
Not Provided
Not Provided
Clinical Life Sciences Ltd.
Clinical Life Sciences Ltd.
Fazer Bakeries Ltd.
Principal Investigator: Päivi Cheney, MD
Study Director: Tiina Suutari, M.Sc. Clinical Life Sciences Ltd.
Clinical Life Sciences Ltd.
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP